Skip to search formSkip to main contentSkip to account menu

Eloxatin

Known as: Eloxatine, Sanofi Synthelabo brand of oxaliplatin, Sanofi brand of oxaliplatin 
National Institutes of Health

Related topics

Related topics

2 relations
10 ML oxaliplatin 5 MG/ML Injection [Eloxatin]

Broader (1)

oxaliplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
COMPARISON OF 5FU-BASE CHEMORADIATION WITH AND WITHOUT ELOXATIN ON PATHOLOGIC COMPLETE RESPONSE IN NEOADJUVANT CHEMO-RADIATION OF RECTAL CANCER
Background and Objectives: To compare pathologic complete response (PCR) in patients with advanced rectal cancer receiving… 
2011
2011
A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
BackgroundDocetaxel and oxaliplatin are active agents for advanced gastric cancer (GC). The combination of these two drugs in a… 
2010
2010
Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer
Abstract Background. ECF (epirubicin, cisplatin, 5-FU) has been a standard first-line regimen in patients with advanced gastro… 
2007
2007
La Coloscopie Virtuelle Paraît Moins Bien Vécue Que la Coloscopie Standard Chez les Patients
LA COLOSCOPIE VIRTUELLE PARAÎT MOINS BIEN VÉCUE QUE LA COLOSCOPIE STANDARD CHEZ LES PATIENTS Le thème était présenté par un… 
2006
2006
Comparative Cytotoxic Activity of Oxitan ® and Eloxatin ® in Colon Cancer Cell Line SW620
Cytotoxic activities of a test formulation (Oxitan ® ) were compared to a reference formulation (Eloxatin ® ) against a colon… 
2005
2005
Oxaliplatin activity in head and neck cancer cell lines
Oxaliplatin (cis-[(1R,2R)-1,2-cyclohexanediamine-N,N′] [oxalato(2-)-O,O′] platinum; Eloxatin) is a third-generation platinum… 
2003
2003
Short-Time Infusion of Oxaliplatin (Eloxatin®) in Combination with Capecitabine (Xeloda®) in Patients with Advanced Colorectal Cancer
Neuropathy exacerbated by exposure to cold is a dose-limiting toxicity of oxaliplatin. The incidence of this side effect is… 
Review
2000
Review
2000
Novel combinations with oxaliplatin.
Oxaliplatin (Eloxatin) is a novel antineoplastic platinum derivative that may exert its cytotoxic effects by blocking DNA… 
2000
2000
Oxaliplatin (Eloxatin): Fortschritte in der Tumortherapie 36th Annual Meeting of the American Society of Clinical Oncology (ASCO), New Orleans, May 2000
Many people are trying to be smarter every day. How's about you? There are many ways to evoke this case you can find knowledge… 
1998
1998
Targeting locoregional immunochemotherapy with new drugs in metastatic liver disease: a promising alternative.
BACKGROUND/AIMS A retrospective report of our experience with adjuvant targeted locoregional immunochemotherapy using new drugs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)